CMND•benzinga•
Why Is Penny Stock Clearmind Gaining Today?
Summary
Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 24, 2024 by benzinga